&lt;Canada Development Corp> said it isconsidering the sale of the 270.8 mln dlrs it holds ofFalconbridge Ltd's 8.5 pct convertible debentures and of its 25pct holding in &lt;CDC Life Sciences Inc>.    It said it made the disclosure in two prospectuses filedtoday with the Ontario Securities Commission.    CDC said one prospectus covers a planned issue of units toraise up to 30 mln dlrs for subsidiary Canterra Energy Ltd's1987 exploration spending. A second prospectus relates to aplanned public sale of four mln common shares which CDC soldprivately to an unidentified investor in December.    CDC said the unit offering will consist of a maximum of18,750 units priced at 1,600 dlrs each. Each unit will comprisean interest in CDC Flow-Through limited partnership and commonshares of Canterra which will be exchanged for CDC commonshares.    Through a series of transactions, investors will receive100 common shares of CDC for each unit, representing a price of16 dlrs a common share. They will also get rights to income taxdeductions equal to the price of each unit.    Agents for the sale are Wood Gundy Inc and DominionSecurities Inc.                         Reuter&#3;